Skip to main content
. 2021 Jun 8;9(6):699–706. doi: 10.1002/ueg2.12095

TABLE 2.

Treatment patterns of the PBC’ patients receiving treatment, at the last follow‐up visit

Treatment Patients, n (%) a (n = 405)
UDCA 404 (99.8)
Fibrates 21 (5.2)
Budesonide 15 (3.7)
Obeticholic acid 5 (1.2)

Abbreviations: PBC, primary biliary cholangitis; UDCA, ursodeoxycholic acid.

a

Column add up greater than 100% because some patients received more than one drug.